Pages that link to "Q46365320"
Jump to navigation
Jump to search
The following pages link to Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease (Q46365320):
Displaying 50 items.
- The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease (Q22305858) (← links)
- Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials (Q24613889) (← links)
- Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD--role of umeclidinium/vilanterol (Q26828602) (← links)
- The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD (Q27349146) (← links)
- Epidemiology and management of common pulmonary diseases in older persons (Q28397465) (← links)
- Muscarinic antagonists in early stage clinical development for the treatment of asthma (Q30396144) (← links)
- The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. (Q30498384) (← links)
- Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma (Q30581306) (← links)
- Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis (Q30620671) (← links)
- Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study (Q31106367) (← links)
- Predictors for mortality in hospitalized patients with chronic obstructive pulmonary disease (Q33941272) (← links)
- Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date (Q33949317) (← links)
- Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective (Q34065276) (← links)
- An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease (Q34065958) (← links)
- Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD (Q35041495) (← links)
- Obesity and COPD: associated symptoms, health-related quality of life, and medication use (Q35204290) (← links)
- Safety of indacaterol in the treatment of patients with COPD (Q35268351) (← links)
- Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines (Q35538249) (← links)
- Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial (Q35686996) (← links)
- Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis (Q35778149) (← links)
- The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study (Q35782391) (← links)
- A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD. (Q35999260) (← links)
- Cause-Specific Deaths in Non-Dialysis-Dependent CKD (Q36104882) (← links)
- Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population (Q36421017) (← links)
- Body mass index and causes of death in chronic kidney disease (Q36591446) (← links)
- Optimizing safety of COPD treatments: role of the nurse practitioner (Q36642198) (← links)
- Safety and tolerability of inhalational anticholinergics in COPD (Q36680246) (← links)
- Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease. (Q36929739) (← links)
- Safety, tolerability and risk benefit analysis of tiotropium in COPD. (Q37115876) (← links)
- Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations (Q37177278) (← links)
- Managing multimorbidity in primary care in patients with chronic respiratory conditions (Q37257970) (← links)
- A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD. (Q37284894) (← links)
- Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage (Q37287627) (← links)
- Pragmatic research and outcomes in asthma and COPD (Q37300877) (← links)
- Optimising treatment for COPD--new strategies for combination therapy (Q37336771) (← links)
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity (Q37367648) (← links)
- Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians (Q37380512) (← links)
- Update in asthma 2008. (Q37474115) (← links)
- Tiotropium HandiHaler in the treatment of COPD: a safety review (Q37474538) (← links)
- Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review (Q37534382) (← links)
- Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care (Q37576593) (← links)
- Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links (Q37644823) (← links)
- Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease (Q37667100) (← links)
- Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease (Q37693967) (← links)
- The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease (Q37748948) (← links)
- The cardiovascular risk of tiotropium: is it real? (Q37766601) (← links)
- Indacaterol maleate for the treatment of chronic obstructive pulmonary disease (Q37773997) (← links)
- Nebulized formoterol: a review of clinical efficacy and safety in COPD. (Q37780450) (← links)
- Medicinal plants useful for treating chronic obstructive pulmonary disease (COPD): Current status and future perspectives (Q37790155) (← links)
- Chronic obstructive pulmonary disease diagnosis and management in older adults (Q37799351) (← links)